β-Lactamase-Dependent Prodrugs—Recent Developments
- 1 July 2000
- journal article
- Published by Elsevier BV in Tetrahedron
- Vol. 56 (31), 5699-5707
- https://doi.org/10.1016/s0040-4020(00)00419-1
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- The β-lactamase cycle: a tale of selective pressure and bacterial ingenuityNatural Product Reports, 1999
- β-Lactam antibiotics, β-lactamases and bacterial resistanceBulletin de l'Institut Pasteur, 1998
- Therapeutic Effects of Monoclonal Antibody−β-Lactamase Conjugates in Combination with a Nitrogen Mustard Anticancer Prodrug in Models of Human Renal Cell CarcinomaJournal of Medicinal Chemistry, 1998
- Antimicrobial Resistance with Focus on β-Lactam Resistance in Gram-Negative BacilliAmerican Journal Of Medicine, 1997
- First clinical experience with ADEPTAdvanced Drug Delivery Reviews, 1996
- Synthesis and β-lactamase-mediated activation of a cephalosporin-taxol prodrugCell Chemical Biology, 1995
- Dual-action cephalosporins: cephalosporin 3'-quaternary ammonium quinolonesJournal of Medicinal Chemistry, 1991
- Cephalosporin 3'-quinolone esters with a dual mode of actionJournal of Medicinal Chemistry, 1990
- Direct observation by proton NMR of cephalosporoate intermediates in aqueous solution during the hydrazinolysis and .beta.-lactamase-catalyzed hydrolysis of cephalosporins with 3' leaving groups: kinetics and equilibria of the 3' elimination reactionJournal of the American Chemical Society, 1986
- Penicillin resistance: the chemistry of .beta.-lactamase inhibitionAccounts of Chemical Research, 1985